Profile: Accelerate Diagnostics Inc (AXDX.O)
10 Mar 2014
Accelerate Diagnostics, Inc., formerly Accelr8 Technology Corporation, incorporated on May 26, 1982, is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company focuses on the development of a rapid diagnostic platform, the BACcel system, intended for rapid diagnosis in life-threatening bacterial infections. The BACcel system applies its technology to eliminate bacterial culturing, thus eliminating the source of delay with testing methods.
The Company’s BACcel system uses bacteriological testing principles, but applies the Company's technology to adapt them to analyze live bacteria extracted directly from a patient specimen. The instrumentation uses automated digital microscopy to measure the responses of extracted live bacterial cells to various test conditions. The Company's system analyzes thousands of these individual cells to arrive at organism identification and antibiotic resistance characteristics. The Company has developed and licensed OptiChem surface coatings for uses in microarraying components. The Company’s OptiChem surface coatings are used in micro-arraying components. OptiChem also offers the ability to apply micro-patterns, enabling advanced analyzer designs. The coating is adaptable to any base material, such as plastics, and can be economically scaled to high-volume production.
The Company competes with Becton Dickinson, bioMerieux, MicroScan, and Trek Diagnostics.
Accelerate Diagnostics Inc
Suite 470, 3950 S. Country Club
TUCSON AZ 85714